Skip to main content
. 2020 Dec;13(3):166–176. doi: 10.2174/1874471013666191230143610

Fig. (3).

Fig. (3)

Comparison of percentage of positive findings between Tektrotyd® and 18F- FDG based on tumor grade. Adapted from Education Exhibit presentation “Neuroendocrine Neoplasms of the Lung: Pathologic Classification and Spectrum of Molecular Imaging Findings”, RSNA Annual Meeting 2012. (A higher resolution / colour version of this figure is available in the electronic copy of the article).